Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MORROW GEORGE J −$2.3M Director sold 59% of stake
  2. ABERNETHY MATT −$363K Chief Financial Officer sold 5% of stake
  3. BENEVICH ERIC −$333K Chief Commercial Officer sold 3% of stake
  4. Boyer David W. −$130K Chief Corp. Affairs Officer sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-28 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −1,431 $107.52 $154K 5,931
2023-08-21 ROBERTS EIRY Chief Medical Officer Sale 10b5-1 −3,198 $107.38 $343K 29,521
2023-08-21 Onyia Jude Chief Scientific Officer Sale 10b5-1 −3,198 $107.37 $343K 9,638
2023-08-21 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −2,132 $107.39 $229K 46,991
2023-08-21 GORMAN KEVIN CHARLES Chief Executive Officer Sale 10b5-1 −9,328 $107.40 $1.0M 499,754
2023-08-21 Gano Kyle Chief Business Development Off Sale 10b5-1 −2,132 $107.41 $229K 130,250
2023-08-21 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −1,404 $107.42 $151K 4,645
2023-08-21 Cooke Julie Chief Human Resources Officer Sale 10b5-1 −2,132 $107.41 $229K 18,087
2023-08-21 Boyer David W. Chief Corp. Affairs Officer Sale 10b5-1 −1,600 $107.41 $172K 6,193
2023-08-21 BENEVICH ERIC Chief Commercial Officer Sale 10b5-1 −1,600 $107.40 $172K 36,436
2023-08-21 ABERNETHY MATT Chief Financial Officer Sale 10b5-1 −2,132 $107.39 $229K 27,131
2023-07-11 POON CHRISTINE A Director Grant or award · Non-Qualified Stock Option +16,375 16,375
2023-05-17 SHERWIN STEPHEN A Director Grant or award · Restricted Stock Unit +4,199 4,199
2023-05-17 Sharp Shalini Director Grant or award · Non-Qualified Stock Option +4,290 4,290
2023-05-17 Sharp Shalini Director Grant or award · Restricted Stock Unit +2,100 2,100
2023-05-17 RASTETTER WILLIAM H Director Grant or award · Non-Qualified Stock Option +8,579 8,579
2023-05-17 POPS RICHARD F Director Grant or award · Restricted Stock Unit +4,199 4,199
2023-05-17 Norwalk Leslie V Director Grant or award · Non-Qualified Stock Option +4,290 4,290
2023-05-17 Norwalk Leslie V Director Grant or award · Restricted Stock Unit +2,100 2,100
2023-05-17 MORROW GEORGE J Director Grant or award · Restricted Stock Unit +4,199 4,199

Page 44 of 49 · 963 trades